Danish Hernia Database, Department of surgery, Herlev Hospital, University of Copenhagen, Herlev, Denmark.
Ann Surg. 2012 Dec;256(6):955-8. doi: 10.1097/SLA.0b013e318254f5b9.
To compare the clinical recurrence rate with reoperation rate for recurrence after ventral hernia repair.
Reoperation is often used as an outcome measure after ventral hernia repair, but it is unknown whether reoperation rate reflects the overall clinical risk for recurrence.
The study cohort was recruited from the Danish Ventral Hernia Database and the Danish National Patient Registry during January 1, 2007, to December 31, 2007. Inclusion criteria were primary umbilical/epigastric (umb/epi) or incisional hernia repair from a regional area of 2 million inhabitants. A prospective clinical follow-up was conducted in January 2011 using a validated questionnaire on reoperation and possible recurrence. Suspicion of recurrence was the criterion for clinical examination. A telephone interview and/or patients' hospital files confirmed reoperation.
A total of 945 patients were eligible, and 902 patients responded to the questionnaire (response rate 95%) with a median postoperative follow-up of 41 months (range 0-48 months). The analysis comprised 646 patients with umb/epi and 256 patients with incisional hernia repair. Clinical examination was required in 241 patients. After umb/epi and incisional hernia repair, the cumulative risks of reoperation and overall recurrence (reoperation + clinical) were 4% and 15% (fourfold underestimation), and 8% and 37% (fivefold underestimation) (P < 0.001), respectively.
Reoperation rate for recurrence 41 months after primary umbilical/epigastric or incisional hernia repair underestimated overall risk of recurrence by four- to fivefolds. This study was registered in www.clinicaltrials.gov (NCT01325246).
比较腹疝修补术后复发的临床复发率与再手术率。
再手术常被用作腹疝修补术后的结果衡量指标,但尚不清楚再手术率是否反映了复发的总体临床风险。
该研究队列是从丹麦腹疝数据库和丹麦全国患者登记处于 2007 年 1 月 1 日至 12 月 31 日招募的,纳入标准为原发性脐/上腹(脐/上腹)或切口疝修复来自一个 200 万居民的区域。前瞻性临床随访于 2011 年 1 月进行,采用验证后的再手术和可能复发的问卷。怀疑复发是进行临床检查的标准。通过电话访谈和/或患者的医院档案确认再手术。
共有 945 名患者符合条件,902 名患者对问卷做出了回应(回应率为 95%),中位术后随访时间为 41 个月(0-48 个月)。分析包括 646 例脐/上腹疝和 256 例切口疝修复。241 例患者需要进行临床检查。在脐/上腹和切口疝修复后,再手术和总复发(再手术+临床)的累积风险分别为 4%和 15%(低估四倍)和 8%和 37%(低估五倍)(P < 0.001)。
原发性脐/上腹或切口疝修复后 41 个月的再手术率低估了总体复发风险,倍数为四到五倍。本研究在 www.clinicaltrials.gov 注册(NCT01325246)。